ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 167,50
-0,26%
Dow Jones
40 003,59
0,34%
DAX
18 704,42
-0,11%
Brent Oil
83,76
0,00%
Bitcoin
66 817,96
-0,39%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Abeona Therapeutics Inc (ABEO)

  7. Abeona Therapeutics Inc (ABEO) Actualités

ABEO Abeona Therapeutics Inc

4,60
0,00 (0,00%)
18 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Abeona Therapeutics Inc ABEO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,00 0,00% 4,60 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,53 4,40 4,62 4,40 4,60
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
15/5/202422:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
15/5/202413:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
15/5/202413:30EDGAR2Form 8-K - Current report
15/5/202413:30GLOBEAbeona Therapeutics Reports First Quarter 2024 Financial..
13/5/202423:03EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/5/202421:06EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/5/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/5/202413:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
03/5/202413:30GLOBEAbeona Therapeutics Announces Pricing of $75 Million..
22/4/202422:05GLOBEAbeona Therapeutics Provides Regulatory Update on Pz-cel
01/4/202414:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/3/202412:30GLOBEAbeona Therapeutics Reports Full Year 2023 Financial Results..
05/3/202413:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
14/2/202422:51EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:20EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202420:38EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
12/2/202423:23EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
07/2/202414:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/2/202422:05GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
01/2/202413:30GLOBEAbeona Therapeutics Announces Progress Update on Pz-cel..
22/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:22EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
08/1/202413:35EDGAR2Form 8-K - Current report
08/1/202413:30GLOBEAbeona Therapeutics Announces $50 Million Credit Facility
15/12/202313:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
04/12/202322:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
27/11/202313:30EDGAR2Form 8-K - Current report
27/11/202313:30GLOBEAbeona Therapeutics Announces FDA Accepts and Grants..
13/11/202314:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202313:35EDGAR2Form 8-K - Current report
13/11/202313:30GLOBEAbeona Therapeutics Reports Third Quarter 2023 Financial..
01/11/202312:30GLOBEAbeona Therapeutics Announces New Employee Inducement Grants..
18/10/202313:30EDGAR2Form 8-K - Current report
17/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/10/202322:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/9/202323:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/9/202313:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/9/202313:30GLOBEAbeona Therapeutics Submits Biologics License Application to..
22/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202322:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/9/202313:30GLOBEAbeona Therapeutics Appoints Madhav Vasanthavada, Ph.D.,..
07/9/202313:30GLOBEAbeona Therapeutics Announces Participation in Upcoming..
30/8/202313:30GLOBEAbeona Therapeutics Announces Positive Pre-BLA Meeting with..

Dernières Valeurs Consultées

NASDAQ
ABEO
Abeona Therapeutics
LSE
AMEC
Amec
EU
HSBBN
Hsbc France 1.875% 23may...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés